Health Canada
- Status: approved
40 Kd Pegylated interferon alfa 2a (40 Kd Pegylated interferon alfa 2a) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Queen Mary University of London is the originator. The local marketing authorisation holder may differ — check the official source linked above.